w66最给利老牌
w66最给利老牌:About Us
w66最给利老牌:About Sino Biopharm
w66最给利老牌:Board of Directors
w66最给利老牌:Senior Management
w66最给利老牌:R&D
R&D Team
w66最给利老牌:Products
w66最给利老牌:Product List
w66最给利老牌:Sustainability
w66最给利老牌:ESG Governance
w66最给利老牌:ESG Management Practices
w66最给利老牌:ESG Reports
w66最给利老牌:Investors
w66最给利老牌:Information Disclosure
w66最给利老牌:Corporate Governance
w66最给利老牌:Presentation
w66最给利老牌:Investor FAQ
Notices
w66最给利老牌:News
w66最给利老牌:Press Releases
Contact
CN
EN
Investors
Home
>
w66最给利老牌:Investors
>
Presentation
w66最给利老牌:
Information Disclosure
w66最给利老牌:
Corporate Governance
w66最给利老牌:
Presentation
w66最给利老牌:
Investor FAQ
w66最给利老牌:
Notices
Presentation
Sino Biopharm 2024 Annual Results Announcement
2025.03.20
Sino Biopharm 2024 Interim Results Announcement
2024.09.19
Sino Biopharm - JPM 2024
2024.01.11
Sino Biopharm 2022 Annual Results Announcement
2023.06.01
Sino Biopharm - JPM
2023.01.16